Sign in
4/A

Changes in Ownership

WEST PHARMACEUTICAL SERVICES INC Filed Acc 0001127602-24-021890

President, CEO and Board Chair sold 66,000 shares at an average $366.65 ($24,199,050)

  • President, CEO and Board Chair acquired 75,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Green Eric Mark President, CEO and Board Chair 2024-05-07 Option exercise 10b5-1 +9,316 $57.38 $534,552 162,224.12 D
Green Eric Mark President, CEO and Board Chair 2024-05-07 Option exercise 10b5-1 +15,684 $57.38 $899,948 177,908.12 D
Green Eric Mark President, CEO and Board Chair 2024-05-07 Option exercise 10b5-1 +41,000 $59.64 $2,445,240 218,908.12 D
Green Eric Mark President, CEO and Board Chair 2024-05-07 Sale 10b5-1 −9,316 $366.64 $3,415,636 209,952.12 D
Green Eric Mark President, CEO and Board Chair 2024-05-07 Sale 10b5-1 −15,684 $366.66 $5,750,678 193,908.12 D
Green Eric Mark President, CEO and Board Chair 2024-05-07 Sale 10b5-1 −41,000 $366.65 $15,032,736 152,908.12 D
Green Eric Mark President, CEO and Board Chair 2024-05-07 Option exercise 10b5-1 +9,000 $59.64 $536,760 161,908.12 D
Derivatives
Green Eric Mark President, CEO and Board Chair 2024-05-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −9,316 0 D
Green Eric Mark President, CEO and Board Chair 2024-05-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −15,684 0 D
Green Eric Mark President, CEO and Board Chair 2024-05-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −41,000 45,732 D
Green Eric Mark President, CEO and Board Chair 2024-05-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −9,000 36,732 D
Open-market sales · 66,000 sh · avg $366.65 · $24,199,050
Loading xslF345X05/form4a.xml…